Pinz Capital Management, LP Cara Therapeutics, Inc. Transaction History

Pinz Capital Management, LP

  • $55.2 Million
  • Q3 2022

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Nov 15, 2021
SELL
$11.55 - $16.06 $94,710 - $131,692
-8,200 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$12.38 - $29.19 $101,516 - $239,358
8,200 New
8,200 $117,000
Q1 2020

May 12, 2020
SELL
$9.12 - $17.78 $80,292 - $156,535
-8,804 Closed
0 $0
Q4 2019

Feb 12, 2020
BUY
$16.11 - $25.98 $141,832 - $228,727
8,804 New
8,804 $142,000

Others Institutions Holding CARA

# of Institutions
102
Shares Held
21.5M
Call Options Held
50K
Put Options Held
0
View Full List

About Cara Therapeutics, Inc.

CARA Quotes by TradingView
  • Ticker CARA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 53,725,900
  • Market Cap $14M
  • Description
  • Cara Therapeutics, Inc., an early commercial-stage biopharmaceutical company, focuses on developing and commercializing chemical entities with a primary focus on pruritus and pain by selectively targeting kappa opioid receptors in the United States. The company is developing product candidates that target the body's peripheral nervous system and...
More about CARA
Track This Portfolio

Track Pinz Capital Management, LP Portfolio

Follow Pinz Capital Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pinz Capital Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Pinz Capital Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email